Terms: = Head and neck cancer AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun AND Clinical Outcome
3 results:
1. MicroRNA Gene Signature for Predicting Mechanisms in Nasopharyngeal Carcinoma: A Case Study on the Potential Application of Circulating Biomarkers.
Wardana T; Oktriani R; Murjayanto CH; Putri DU; Anwar SL; Aryandono T; Haryana SM
Microrna; 2023; 12(1):29-44. PubMed ID: 36121076
[TBL] [Abstract] [Full Text] [Related]
2. Impact Exerted by Nutritional Risk Screening on clinical outcome of Patients with Esophageal cancer.
Wang R; Cai H; Li Y; Chen C; Cui Y
Biomed Res Int; 2018; 2018():7894084. PubMed ID: 29780831
[TBL] [Abstract] [Full Text] [Related]
3. AXL mediates resistance to cetuximab therapy.
Brand TM; Iida M; Stein AP; Corrigan KL; Braverman CM; Luthar N; Toulany M; Gill PS; Salgia R; Kimple RJ; Wheeler DL
Cancer Res; 2014 Sep; 74(18):5152-64. PubMed ID: 25136066
[TBL] [Abstract] [Full Text] [Related]
